secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIODESIX INC (BDSX)
CIK:        0001439725
Form:       8-K
Filed at:   2022-11-21T23:59:59+00:00
Accession:  0000950170-22-025530
Event type: debt
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 1.02, 2.03, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biodesix raises $70.7M via $50M term loan and $40.3M equity; retires $24M in debt
--------------------------------------------------------------------------------

- Entered $50M Perceptive term loan; $30M drawn at close, two $10M tranches available on revenue milestones.
- Priced public offering of 35.075M shares at $1.15; gross proceeds $40.3M; net ~$37.5M.
- Used $24M of net proceeds to repay Streeterville note ($18.2M) and SVB term loan ($5.8M).
- Loan is interest-only for 5 years at SOFR (floor 3%) + 9%; matures Nov 2027; warrants for up to 5M shares at $1.0648.
- Management purchased 278,514 shares at $1.15 in a private placement; lock-up 90 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1439725/000095017022025530/0000950170-22-025530-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1439725/000095017022025530/bdsx-20221116.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-025530

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer